Search - tctmd.com

Displaying 201 - 220 of 232

Sort: Relevancy | Date

Presentation TCT 2014

The Emboline Aortic Embolic Protection Technology

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Scott Russell

September 15, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Davide Capodanno

September 12, 2014

Presentation

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Presenter: M. Hornung

July 28, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation Fellows 2014

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish Parikh

April 13, 2014

Presentation

Emboline - Aortic Embolic Protection Solutions

Presenter: Amir Belson

December 02, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation TCT 2013

Predictors Of Carotid Clamping Intolerance During Carotid Artery Stenting With Proximal Embolic Protection Device. Results From An Italian Registry.

Presenter: Giuseppe Giugliano

October 29, 2013

Presentation TCT 2013

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Davide Capodanno

October 27, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Presenter: L. Bijuklic

June 06, 2013

Presentation Fellows 2013

Thrombectomy and Embolic Protection Systems

Presenter: Manish Parikh

April 16, 2013

Presentation TCT 2013

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

Advertisement

The Emboline Aortic Embolic Protection Technology

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Atherotomy, Atherectomy, and Embolic Protection

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Emboline - Aortic Embolic Protection Solutions

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Predictors Of Carotid Clamping Intolerance During Carotid Artery Stenting With Proximal Embolic Protection Device. Results From An Italian Registry.

Atherotomy, Atherectomy, and Embolic Protection

Cerebral Embolic Protection Devices

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Thrombectomy and Embolic Protection Systems

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content